Are HPV-negative lesions concerned for the introduction of primary HPV testing for cervical cancer screening in Japan?
Misako HideshimaMariko HashiguchiAtsuko HondaYasushi UmezakiRyoichi OkumaTakako HikariAsako FukudaKaoru OkugawaMasatoshi YokoyamaPublished in: The journal of obstetrics and gynaecology research (2023)
HPV-negative CIN2+ or cervical adenocarcinoma is not a concern for the introduction of primary HPV screening in Japan. Primary HPV testing in cervical cancer screening is considered a feasible method that can be used in Japan, although an algorithm suitable for Japan and a national-level management system need to be established.